Sedadex RSS Authorised This medicine is authorised for use in the European Union dexmedetomidine Medicine Veterinary Authorised
Page contentsPage contents Overview Product information Product details Authorisation details Assessment history News on Sedadex Topics Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Sedadex : EPAR - Summary for the public English (EN) (81.94 KB - PDF)First published: 12/09/2016 Last updated: 14/10/2025 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View español (ES) (81.97 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View čeština (CS) (93.99 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View dansk (DA) (83.34 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Deutsch (DE) (82.76 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View eesti keel (ET) (82.18 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View ελληνικά (EL) (93.76 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View français (FR) (82.44 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View hrvatski (HR) (92.27 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View íslenska (IS) (83.29 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Gaeilge (GA) (83.57 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View italiano (IT) (82.29 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View latviešu valoda (LV) (94.29 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View magyar (HU) (94.15 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Malti (MT) (95.95 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Nederlands (NL) (82.05 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View norsk (NO) (82 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View polski (PL) (95.62 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View português (PT) (83.01 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View română (RO) (94.17 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View slovenčina (SK) (94.08 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View slovenščina (SL) (82.27 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Suomi (FI) (81.54 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View svenska (SV) (82.05 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Product information Sedadex : EPAR - Product Information English (EN) (81.49 KB - PDF)First published: 12/09/2016 Last updated: 14/10/2025 View Other languages (25) български (BG) (91.78 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View español (ES) (81.51 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View čeština (CS) (92.48 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View dansk (DA) (82.05 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Deutsch (DE) (81.72 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View eesti keel (ET) (81.22 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View ελληνικά (EL) (91.79 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View français (FR) (81.63 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View hrvatski (HR) (91.56 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View íslenska (IS) (81.52 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Gaeilge (GA) (81.36 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View italiano (IT) (81.76 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View latviešu valoda (LV) (92.14 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View lietuvių kalba (LT) (92.19 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View magyar (HU) (92.76 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Malti (MT) (93.86 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Nederlands (NL) (81.15 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View norsk (NO) (81.52 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View polski (PL) (93.22 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View português (PT) (82.53 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View română (RO) (91.73 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View slovenčina (SK) (81.75 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View slovenščina (SL) (81.76 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Suomi (FI) (81.11 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View svenska (SV) (81.47 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Latest procedure affecting product information: Sedadex : EPAR - All Authorised presentations English (EN) (81.94 KB - PDF)First published: 12/09/2016 Last updated: 14/10/2025 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View español (ES) (81.97 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View čeština (CS) (93.99 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View dansk (DA) (83.34 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Deutsch (DE) (82.76 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View eesti keel (ET) (82.18 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View ελληνικά (EL) (93.76 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View français (FR) (82.44 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View hrvatski (HR) (92.27 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View íslenska (IS) (83.29 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Gaeilge (GA) (83.57 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View italiano (IT) (82.29 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View latviešu valoda (LV) (94.29 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View magyar (HU) (94.15 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Malti (MT) (95.95 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Nederlands (NL) (82.05 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View norsk (NO) (82 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View polski (PL) (95.62 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View português (PT) (83.01 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View română (RO) (94.17 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View slovenčina (SK) (94.08 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View slovenščina (SL) (82.27 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Suomi (FI) (81.54 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View svenska (SV) (82.05 KB - PDF) First published: 12/09/2016 Last updated: 14/10/2025 View Product details Name of medicine Sedadex Active substance Dexmedetomidine hydrochloride International non-proprietary name (INN) or common name dexmedetomidine Pharmacotherapeutic groupPsycholepticsHypnotics and sedatives Authorisation details EMA product number EMEA/V/C/004202 Assessment history Expand section Collapse section Changes since initial authorisation of medicine Sedadex : EPAR - Procedural steps taken and scientific information after authorisation English (EN) (81.94 KB - PDF)First published: 22/12/2016 Last updated: 14/10/2025 View Initial marketing authorisation documents Sedadex : EPAR - Public assessment reportAdopted English (EN) (81.49 KB - PDF)First published: 12/09/2016 Last updated: 14/10/2025 View CVMP summary of positive opinion for SedadexAdopted Reference Number: EMA/CVMP/371866/2016 English (EN) (79.11 KB - PDF)First published: 17/06/2016 Last updated: 17/06/2016 View News on Sedadex Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-12 February 202514/02/2025 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 15-17 June 202118/06/2021 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 8-10 October 201911/10/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 22-24 January 201925/01/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 5–7 December 201708/12/2017 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 13-15 June 201716/06/2017 Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of 14-16 June 201617/06/2016 Topics Medicines This page was last updated on 14/10/2025 Share this page